Cervical cancer shot gains acceptance

Published: Oct. 10, 2008 at 7:04 PM

ATLANTA, Oct. 10 (UPI) -- One in four teenage girls received at least one dose of a relatively new vaccine against cervical cancer, U.S. health officials said.

The 25.1 percent vaccination rate among 13- to 17-year-olds provides the first national estimate of use of Merck & Co.'s Gardasil vaccine, the Centers for Disease Control and Prevention said.

Gardasil, administered in a three-dose series, is a vaccine against certain types of human papillomavirus, which infects the skin and mucous membranes.

Human papillomavirus, or HPV, infection causes nearly all cases of cervical cancer, the second leading cause of death from cancer in women worldwide.

Nearly 4,000 women die of cervical cancer in the United States each year.

"For a new vaccine, 25 percent coverage is really very good," Immunization Services Director Lance Rodewald said.

Vaccine proponents had hoped for higher vaccination rates.

Both men and women can be HPV carriers. Studies are being conducted to determine the efficacy of vaccinating boys with Gardasil.

© 2008 United Press International, Inc. All Rights Reserved.
Order reprints



Additional News Stories
What makes holidays special can kill pets
NHL: Chicago 7, San Jose 2
NBA: Portland 93, New Jersey 83
NBA: Sacramento 111, New York 97
COL BKB: Kentucky 73, Stanford 65 (OT)
NHL: Anaheim 3, Carolina 2
NHL: Los Angeles 3, Edmonton 1
fark
The six most horrific lessons ever taught in elementary school
Thirty-two percent of American men are obviously watching Alton Brown more than the Dallas Cowboys...
Old and Busted: Crashing a wedding reception. New Hotness: Crashing Obama's first State Dinner
Truthers won't be getting much sleep this week after Wikileaks posts 573,000 pager messages from...
Photoshop this Unisphere
Coño man, it has been 10 years since Elián touch our hearts, Ft Lauderdale